Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pico Multisite dressing kit 15cm x 20cm
20032100100
|
Pico Multisite dressing kit 15cm x 20cm | Wound Management & Other Dressings | Dressings | No data available |
|
Pico Multisite dressing kit 20cm x 25cm
20032100101
|
Pico Multisite dressing kit 20cm x 25cm | Wound Management & Other Dressings | Dressings | No data available |
|
Pifeltro 100mg tablets
0503010ATBBAAAA
|
Pifeltro | Doravirine | Infections | No data available |
|
Pilocarpine hydrochloride 0.125% eye drops
1106000X0AAA3A3
|
Pilocarpine hydrochloride (Eye) | Pilocarpine hydrochloride | Eye | No data available |
|
Pilocarpine hydrochloride 0.25% eye drops
1106000X0AAAGAG
|
Pilocarpine hydrochloride (Eye) | Pilocarpine hydrochloride | Eye | No data available |
|
Pilocarpine hydrochloride 0.5% eye drops
1106000X0AABPBP
|
Pilocarpine hydrochloride (Eye) | Pilocarpine hydrochloride | Eye | No data available |
|
Pilocarpine hydrochloride 1.25mg/5ml oral solution
1203050P0AAAEAE
|
Pilocarpine hydrochloride (Systemic) | Pilocarpine hydrochloride | Ear, Nose and Oropharynx | No data available |
|
Pilocarpine hydrochloride 2.5mg/5ml oral solution
1203050P0AAAGAG
|
Pilocarpine hydrochloride (Systemic) | Pilocarpine hydrochloride | Ear, Nose and Oropharynx | No data available |
|
Pilocarpine hydrochloride 3% eye drops
1106000X0AAADAD
|
Pilocarpine hydrochloride (Eye) | Pilocarpine hydrochloride | Eye | No data available |
|
Pilocarpine hydrochloride 3mg/5ml oral solution
1203050P0AAACAC
|
Pilocarpine hydrochloride (Systemic) | Pilocarpine hydrochloride | Ear, Nose and Oropharynx | No data available |
|
Pilocarpine hydrochloride 4% eye gel
1106000X0AABDBD
|
Pilocarpine hydrochloride (Eye) | Pilocarpine hydrochloride | Eye | No data available |
|
Pilocarpine hydrochloride 5mg/5ml oral solution
1203050P0AAADAD
|
Pilocarpine hydrochloride (Systemic) | Pilocarpine hydrochloride | Ear, Nose and Oropharynx | No data available |
|
Pilocarpine hydrochloride 6% eye drops
1106000X0AAAIAI
|
Pilocarpine hydrochloride (Eye) | Pilocarpine hydrochloride | Eye | No data available |
|
Pilocarpine hydrochloride 6% eye drops preservative free
1106000X0AAA4A4
|
Pilocarpine hydrochloride (Eye) | Pilocarpine hydrochloride | Eye | No data available |
|
Pilocarpine hydrochloride 8% eye drops
1106000X0AAARAR
|
Pilocarpine hydrochloride (Eye) | Pilocarpine hydrochloride | Eye | No data available |
|
Pilocarpine hydrochloride 8mg/5ml oral solution
1203050P0AAAHAH
|
Pilocarpine hydrochloride (Systemic) | Pilocarpine hydrochloride | Ear, Nose and Oropharynx | No data available |
|
Pilocarpine nitrate 1% eye dps 0.5ml ud preservative free
1106000Y0AAAAAA
|
Pilocarpine nitrate | Pilocarpine nitrate | Eye | No data available |
|
Pilocarpine nitrate 4% eye dps 0.5ml ud preservative free
1106000Y0AAACAC
|
Pilocarpine nitrate | Pilocarpine nitrate | Eye | No data available |
|
Pilogel 4% eye gel
1106000X0BFAABD
|
Pilogel | Pilocarpine hydrochloride | Eye | No data available |
|
Pimozide 1.25mg/5ml oral suspension
0402010R0AAAGAG
|
Pimozide | Pimozide | Central Nervous System | No data available |
|
Pimozide 2mg tablets
0402010R0AAAAAA
|
Pimozide | Pimozide | Central Nervous System | No data available |
|
Pindolol 10mg / Clopamide 5mg tablets
020400010AAAAAA
|
Pindolol/clopamide | Pindolol with diuretic | Cardiovascular System | No data available |
|
Pindolol 15mg tablets
0204000P0AAABAB
|
Pindolol | Pindolol | Cardiovascular System | No data available |
|
Pinetarsol 1.6% gel
1305020C0BSAAFB
|
Pinetarsol | Tars | Skin | No data available |
|
Pinetarsol 2.3% bath oil
1305020C0BSABFC
|
Pinetarsol | Tars | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.